Herbal Products as Complementary or Alternative Medicine for the Management of Hyperglycemia and Dyslipidemia in Patients with Type 2 Diabetes: Current Evidence Based on Findings of Interventional Studies.
Hossein FarhadnejadNiloufar SaberAsal Neshatbini TehraniMitra Kazemi JahromiEbrahim MokhtariMostafa NorouzzadehFarshad TeymooriGolaleh AsghariParvin MirmiranFereidoun AziziPublished in: Journal of nutrition and metabolism (2024)
Type 2 diabetes (T2D) is known as a major public health problem with a noticeable adverse impact on quality of life and health expenditures worldwide. Despite using routine multiple pharmacological and nonpharmacological interventions, including diet therapy and increasing physical activity, controlling this chronic disease remains a challenging issue, and therapeutic goals are often not achieved. Therefore, recently, other therapeutic procedures, such as using herbal products and functional foods as complementary or alternative medicine (CAM), have received great attention as a new approach to managing T2D complications, according to the literature. We reviewed the existing evidence that supports using various fundamental medicinal herbs, including cinnamon, saffron, ginger, jujube, turmeric, and barberry, as CAM adjunctive therapeutic strategies for T2D patients. The current review addressed different aspects of the potential impact of the abovementioned herbal products in improving glycemic indices and lipid profiles, including the effect size reported in the studies, their effective dose, possible side effects, herbs-drug interactions, and their potential action mechanisms.
Keyphrases
- public health
- physical activity
- type diabetes
- end stage renal disease
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- systematic review
- glycemic control
- case control
- human health
- prognostic factors
- working memory
- cardiovascular disease
- stem cells
- global health
- health insurance
- peritoneal dialysis
- metabolic syndrome
- mesenchymal stem cells
- climate change
- adipose tissue
- patient reported outcomes
- insulin resistance
- sleep quality
- social media
- adverse drug
- electronic health record